Stay updated on GECKO Clinical Trial: MOR106 + Topical Corticosteroids
Sign up to get notified when there's something new on the GECKO Clinical Trial: MOR106 + Topical Corticosteroids page.

Latest updates to the GECKO Clinical Trial: MOR106 + Topical Corticosteroids page
- Check4 days agoChange DetectedAdded a Locations section listing trial sites by state (CA, FL, IL, IN, KY, NY, TX) and updated the page to revision v3.3.3, while removing prior state-specific location entries.SummaryDifference0.8%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedFooter now displays Revision: v3.3.2, replacing Revision: v3.2.0. This is a routine site update and does not modify study information on the page.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved the government funding/operating status notice that previously appeared on the page.SummaryDifference0.4%

- Check55 days agoChange DetectedThe page now shows a termination notice stating that MOR106 development in atopic dermatitis was stopped for futility. This update appears in the Study Overview and updates the study's status and related details.SummaryDifference0.4%

- Check83 days agoChange DetectedSignificant changes: updated operating status notice and version to v3.2.0; removed previous v3.1.0 reference.SummaryDifference4%

- Check90 days agoChange DetectedAdded revision label v3.1.0; removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and the older revision note v3.0.2.SummaryDifference0.6%

Stay in the know with updates to GECKO Clinical Trial: MOR106 + Topical Corticosteroids
Enter your email address, and we'll notify you when there's something new on the GECKO Clinical Trial: MOR106 + Topical Corticosteroids page.